Sweden: Qlife borrows Skr20m to complete development and registration process

Medical device company, Qlife, has entered into six-month loan agreements of up to Skr20m (US$1.94m) to finalize the product development and registration for CRP and PHE products during 2022. The loans, paying 1.5% in monthly interest, are granted by Modelio Equity and a large private shareholder in Qlife. There is an additional 5% set-up fee….

You must be a HMI Subscriber to view this content.

Subscribe Now »